Lack of B cell precursors in marrow transplant recipients with chronic graft-versus-host disease

American Journal of Hematology

Volumn 52, Issue 2, 1996, Pages 82-89

  Storek, Jan ^a,c   Witherspoon, Robert P ^a   Webb, Dale ^b   Storb, Rainer ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Providence Hospital   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

B lymphocytes; bone marrow transplantation; chronic graft vs. host disease

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; CD34 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; MEMBRANE METALLOENDOPEPTIDASE;

ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STEM CELL; BONE MARROW; CYTOLOGY; DRUG EFFECT; HEMATOPOIETIC STEM CELL; LYMPHOCYTE COUNT; PATHOLOGY; TIME;

ANTIGENS, CD34; B-LYMPHOCYTES; BONE MARROW; BONE MARROW TRANSPLANTATION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE COUNT; NEPRILYSIN; TIME FACTORS;

EID: 0029664331     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199606)52:2<82::AID-AJH3>3.0.CO;2-1     Document Type: Article

References (36)

1. Lum LG: Immune recovery after bone marrow transplantation. Hemat/ Oncol Clin North Am 4:659, 1990.
2. Witherspoon RP: Immunologic reconstitution after high-dose chemoradiotherapy and allogeneic or autologous bone marrow or peripheral blood hematopoietic stem cell transplantation. In Armitage JO, Antman KH (eds): "High-Dose Cancer Therapy," Ed 2. Baltimore: Williams & Wilkins, pp 258-262, 1995.
3. Storek, J, Saxon A: Reconstitution of B cell immunity following bone marrow transplantation. Bone Marrow Transplant 9:395, 1992.
4. Parkman R: Immunological reconstitution following bone marrow transplantation. In Forman SJ, Blume KG, Thomas ED (eds): "Bone Marrow Transplantation." Boston: Blackwell, 1994.
5. Witherspoon RP, Storb R, Ochs HD, et al: Recovery of antibody production in human allogeneic marrow graft recipients: Influence of time posttransplantation, the presence or absence of chronic GVHD, and antithymocyte globulin treatment. Blood 58:360, 1981.
6. Abe J, Emura I, Ohnishi Y: Morphological and immunocytochemical examinations on development of B cells in human embryonic and fetal liver. Acta Haematol Jpn 51:712, 1989.
7. Kotylo PK, Baenzinger JC, Yoder MC, Engle WA, Bolinger CD: Rapid analysis of lymphocyte subsets in cord blood. Am J Clin Pathol 93:262, 1990.
8. Hannet I, Erkeller-Yuksel F, Lydyard P, Deneys V, Debruyere M: Developmental and maturational stages in human blood lymphocyte subpopulations. Immunol Today 13:215, 1992.
9. Caldwell CW, Poje E, Helikson MA: B cell precursors in normal pediatric bone marrow. Am J Clin Pathol 96:816, 1991.
10. Small TN, Keever CA, Weiner-Fedus S, Heller G, O'Reilly RJ, Flomenberg N: B cell defferentiation following autologous, conventional, or T cell-depleted bone marrow transplantation: a recapitulation of normal B ontogeny. Blood 76:1647, 1990.
11. Storek J, Ferrara S, Ku N, Giorgi JV, Champlin RE, Saxon A: B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant 12:387, 1993.
12. Osmond DG: The turnover of B cell populations. Immunol Today 14:34, 1993.
13. Sprent J, Tough DF: Lymphocyte life-span and memory. Science 265:1395, 1994.
14. Loken MR, Shah VO, Dattilio KL, Civin CI: Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 70:1316, 1987.
15. Ryan D, Kossover S, Mitchell S, Frantz C, Hennessy L, Cohen H: Subpopulations of Common Acute Lymphoblastic Leukemia Antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens. Blood 68:417, 1986.
16. Pontvert-Delucq S, Breton-Gorius J, Schmitt C, et al: Characterization and functional analysis of adult human bone marrow cell subsets in relation to B-lymphoid development. Blood 82:417, 1993.
17. Hollander Z. Shah VO, Civin CI, Loken MR: Assessment of proliferation during maturation of the B lymphoid lineage in normal human bone marrow. Blood 71:528, 1988.
18. Clift RA, Buckner CD, Thomas ED, et al: Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 84.2036, 1994.
19. Tutschka PJ, Copelan EA, Klein JP: Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 70:1382, 1987.
20. Wheeler C, Antin JH, Churchill WH, et al: Cyclophosphamide, carmustine and etoposide with autologous bone marrow transplantation in refractory Hodgkin's lymphoma: A dose-finding study. J Clin Oncol 8:648, 1990.
21. Storb R, Deeg HJ, Whitehead J, et al: Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute GVHD after marrow transplantation for leukemia. N Engl J Med 314:729, 1986.
22. Deeg HJ, Loughran TP Jr, Storb R, et al: Treatment of human acute GVHD with anti-thymocyte globulin and cyclosporine with or without mthylprednisolone. Transplantation, 40:162, 1985.
23. Sullivan KM, Witherspoon RP, Storb R, et al: Alternating-day cyclosporine and prednisone for treatment of high-risk chronic GVHD. Blood 72:555, 1988.
24. Loken MR, Shah VO, Dattilio KL, Civin CI: Flow cytometric analysis of human bone marrow. I. Normal erythroid development. Blood 69:255, 1987.
25. Bengtsson M, Gordon J, Flores-Romo L, et al: B cell reconstitution after autologous bone marrow transplantation: Increase in serum CD23 (IgE-binding factor) precedes IgE and B cell regeneration. Blood 73:2139, 1989.
26. Uckun FM, Haissig S, Ledbetter JA, et al: Developmental hierarchy during early human B cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19+ B cell precursors by an anti-CD19 pan-B cell immunotoxin containing pokeweed anti viral protein. Blood 79:3369, 1992.
27. +, pre-B and B cells in bone marrow after allogeneic bone marrow transplantation. Transplantation 43:865, 1987.
28. Leitenberg D, Rappeport JM, Smith BR: B cell precursor bone marrow reconstitution after bone marrow transplantation. Am J Clin Pathol 102:231, 1994.
29. Golde DW, Hocking WG, Quan SG, Sparkes RS, Gale RP: Origin of human bone marrow fibroblasts. Br J Haematol 44:183, 1980.
30. Gordon MY: The origin of stromal cells in patients treated by BMT. Bone Marrow Transplant 3:247, 1988.
31. Witherspoon RP, Lum LG, Storb R: Immunologic reconstitution after human marrow grafting. Semin Hematol 21:2, 1984.
32. Roux E, Helg C, Chapuis B, Jeannet M. Roosnek E: Evolution of mixed chimerism after allogeneic BMT as determined on granulocytes and mononuclear cells by the PCR. Blood 79:2775, 1992.
33. Okamoto T, Kanamaru A, Kakishita E, Nagai K: Stromal fibroblastic and hematopoietic progenitors in patients with GVHD. Intl J Hematol 54:299, 1991.
34. Holmberg L, Torok-Storb B: Mechanisms of failure of sustained engraftment. In Atkinson K (ed): "Clinical Bone Marrow Transplantation." Cambridge: Cambridge University Press, 1994.
35. Nakao S, Nakatsumi T, Chuhjo T, et al : Analysis of late graft failure after allogeneic BMT: Detection of residual host cells using amplification of variable number of tandem repeats. Bone Marrow Transplant 9:107, 1992.
36. Klumpp TR: Immunohematologic complications of bone marrow transplantation. Bone Marrow Transplant 8:159, 1991.